Our findings reveal the crucial role of the RAB33A-RhoC axis in cervical cancer metastasis and indicate that Rho inhibitors, such as fasudil hydrochloride, may benefit a subset of cervical cancer patients. This evidence concerns the gene RAB33A and cervical carcinoma.